Skip to main content

Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.

Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, Gonzalez de Castro D, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA

Publication: J Clin Pathol (2015) • Vol 68(2) • Page 111-8PMID: 25430497View on PubMed

Purpose

The purpose of this paper was to determine the effects of DNA extraction and quantification methods on PCR success and mutation detection using engineered formalin-fixed paraffin-embedded (FFPE) specimens and a single FFPE tonsil specimen.

Conclusion

Mutation analysis failed to identify introduced mutations for 11.9% of the engineered specimens. 3 of the 4 failures were due to insufficient DNA quantity with the fourth failure due to Sanger sequencing error. While the variability in DNA yield depended on the method of measurement, amplifiable DNA was obtained by all methods, and PCR inhibition was minimal. However, the measurement of DNA yield was 5.1 fold higher by Nanodrop than Qubit, and the use of Nanodrop resulted in quantification of DNA from negative controls containing no cells.

Studies (1)

Purpose

The purpose of this study was to determine the effects of DNA extraction and quantification methods on PCR success and mutation detection using engineered FFPE specimens and a single FFPE tonsil specimen. For consistency, specimens were comprised of MCF10A and SW48 cells which had known mutations introduced into BRAF and EGFR. Blocks were designed to have 160,000 cells/section. No specifics of the FFPE tonsil specimen(s) were provided. DNA extractions were done at 13 different laboratories blinded to specimen contents using one of 5 methods for extraction and one of two or both methods for quantification.

Summary of Findings

The variation in DNA yield between laboratories for the engineered specimens was not significant, but quantified yields were 1.3 fold higher than expected based on the number of cells. Importantly, laboratories reported DNA yields averaging 235.8 ng from negative control specimens lacking cells, but this was only true when Nanodrop was used for quantification and not Qubit. Further there was an 11.9% failure rate for mutation detection which was attributed to the failure to obtain sufficient DNA from 2 of 2 and 1 of 4 specimens at two laboratories and a single missed call by Sanger sequencing at another laboratory. DNA extraction methods differed between the laboratories and resulted in variances in DNA yield (52-82%), but amplifiable DNA was obtained by all methods, and there was no evidence of substantial PCR inhibition. Importantly, while amplifiable DNA of 100-400 bp was obtained from engineered specimens, the tonsil specimen yielded DNA that was highly degraded and only allowed for reliable amplification of the 100 bp product, although weak amplification of other bands was possible in specimens from some laboratories. The measurement of DNA yield as assessed by Nanodrop (spectrophotometry) was only modestly correlated with that by Qubit (fluoremetry) (R=0.48), with Nanodrop reading averaging 5.1 fold higher than Qubit readings, and this difference was accentuated with the non-engineered specimen which had degraded DNA.

  • Biospecimens

    TissueTonsil
    CellOther
  • Preservation Types

    Formalin
  • Diagnoses

    Not specified
  • Platforms

    DNADNA sequencing
    DNAPCR
    DNAFluorometry
    DNASpectrophotometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Analyte Extraction and PurificationAnalyte isolation method
    COBAS
    Dneasy
    EZ1
    QIAamp
    RecoverAll
    PCR SpecificLength of gene fragment
    100 bp
    200 bp
    300 bp
    400 bp
    Spectrophotometry SpecificTechnology platform
    Qubit